Epistem Limited

disease & therapeutic research models

Inflammatory Bowel Disease

GI Toxicity and Mucositis

Immune Cell Assays

Rheumatoid Arthritis

services

Gene Expression Analysis

Histology and IHC Services

Laser Capture Microdissection

Analytical Services

Plucked Hair Analysis

Spotlight On...

Ileal apoptosis and microbiota mediate colon cancer treatment efficacy
A recent study sheds further light on the interdependent relationship between the intestinal epithelium, the intestinal microbiome and host immunity,…
Enrichment of CpG island shore region hypermethylation in epigenetic breast …
Scientists have demonstrated that normal tissue from the tumour harbouring breast is epigenetically different from normal tissue of the opposite…
Immune cell proﬁling of COVID-19 patients in the recovery stage by …
Authors of a recent COVID-19 study have applied single cell sequencing to characterise the immune cell repertoire and gene expression changes in…
Heterogeneous components of lung adenocarcinomas harbour distinct EGFR …
A recent study using laser capture microdissection demonstrated that different areas of the same lung adenocarcinoma tissue can harbour both…
Reducing intestinal inflammation with secondary bile acids
Intestinal inflammation was shown to be associated with reduced levels of secondary bile acids and bacteria of the Ruminococcaceae family in a recent…

Announcements

ANNOUNCING:
RECRUITING: SENIOR OR PRINCIPAL SCIENTIST - FIBROSIS MODELS
Epistem are on the lookout for an individual with a strong background in fibrotic remodeling with industry experience or 5 years post-doc
NEWS: Epistem licence Hubrecht Organoid Technology to expand preclinical toxicology service portfolio
2019-07-15
Epistem Limited has announced the expansion of its in vitro model portfolio by the completion of an agreement with Hubrecht Organoid Technology (HUB)…
NEWS: 10 Years GCLP Accreditation at Epistem
2019-01-11
We are pleased to announce the successful GCLP re-accreditation of our laboratories.

© 2018, 2020 Epistem Ltd.

site map | privacy policy | terms of use | contact us

Call us on +44 (0)161 850 7600 or email info@epistem.co.uk

Accelerating Drug Development with Innovative Services

This site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this again